Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0021 Transporter Info | ||||
Gene Name | SLC15A1 | ||||
Transporter Name | Peptide transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC15A1 gene in colon cancer condition | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco2-BBE) | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) has been reported to activate the transcription of SLC15A1 gene in colon cancer condition, which leads to an increased expression of the drug transporter Peptide transporter 1. | |||||
NFE2L2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC15A1 gene in colon cancer condition | [2] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous resveratrol, has been reported to activate the transcription of SLC15A1 gene in colon cancer condition , which leads to an increased expression of the drug transporter Peptide transporter 1. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PPARA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC15A1 gene in effects of | [3] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glycylsarcosine | |||||
Studied Phenotype |
Effects of hunger [ICD11: NF07.0] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Wistar rats | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA) has been reported to activate the transcription of SLC15A1 gene in effects of hunger condition, which leads to an increased expression of the drug transporter Peptide transporter 1. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
CDX2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC15A1 gene in gastric cancer condition | [4] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
Gastric cancer [ICD11: 2B72] | |||||
Tissue |
Stomach | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human gastric cancer cell isolates | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2) has been reported to activate the transcription of SLC15A1 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Peptide transporter 1. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC15A1 gene in colitis condition | [5] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
Colitis [ICD11: 1A40] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
FVB mice | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2) has been reported to activate the transcription of SLC15A1 gene in colitis condition, which leads to an increased expression of the drug transporter Peptide transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.